ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Ultrasound Therapy for Fibromyalgia and Lyme Disease

Curcumin: The All In One Solution, Part 2

What Are the Benefits of Vitamin K2?

Vitamin D deficiency + high fat diet = metabolic syndrome

Why You Should Take Your Apple Cider Vinegar at Night

Use Burdock Oil to Promote Healthy Hair Growth

People with forms of early-onset Parkinson's disease may benefit from boosting niacin in diet, resea...

Meet Your Weight Loss Goals

AMA journal associates iron deficiency with hearing loss

Why the Mediterranean Diet Is so Successful

 
Print Page
Email Article

A randomized, double-blind, placebo-controlled trial of dolasetron, a 5-HT3 receptor antagonist, in patients with fibromyalgia – Source: European Journal of Pain, Oct 29, 2010

  [ 13 votes ]   [ Discuss This Article ]
By Pascale Vergne-Salle, et al. • www.ProHealth.com • November 8, 2010


[Note: The 5-HT3 receptor antagonist dolasetron (trade name Anzemet®) is mainly prescribed to reduce activity of the vagus nerve – the nerve that conveys information back & forth between the organs & some skeletal muscles and the brain. Because the vagus nerve is responsible for activating the brain’s vomiting center, dolasetron is used after chemo, surgery, radiation, acute gastroenteritis, etc. to reduce nausea/vomiting.]

Objective: The purpose of the study was to evaluate the efficacy and safety of dolasetron for symptomatic relief of pain associated with fibromyalgia (FM).

Methods: This prospective, double-blind, placebo-controlled trial randomly assigned 60 patients with FM to receive placebo (n=31) or dolasetron (n=29) 12.5mg/d via the intravenous route on 4 days at:
• Baseline (M0),
• 1 month (M1),
• 2 months (M2),
• And 3 months (M3),

With follow-up to month 12.

The primary outcome variable was the reduction in pain intensity measured by visual analogue scale (VAS) between M0 and M3. The secondary outcome variables were patient global impression of change (PGIC), the FM impact questionnaire, assessment of quality of life (SF-36), the hospital anxiety and depression scale, the manual tender point count, and functional symptoms associated with FM.

Results: Reduction in pain intensity at M3 was significantly greater in dolasetron-treated patients (p=0.04, -21.3 on a 0-100 scale) compared with placebo controls (-5.9).

More patients in the dolasetron group had 30% or greater and 50% or greater improvement in pain (42.5% and 28% respectively in the dolasetron group versus 25% and 16% in the placebo group).

The PGIC was significantly greater in the dolasetron group at M3 (p=0.02).

The other secondary outcomes failed to reach statistical significance.

The most common adverse events were constipation, nausea, dizziness and headache, with no significant differences between the two groups.

Conclusion: Intermittent IV dolasetron was safe and efficacious for the reduction of pain intensity associated with FM at 3 months.

Source: European Journal of Pain, Oct 29, 2010. PMID: 21036635, by Vergne-Salle P, Dufauret-Lombard C, Bonnet C, Simon A, Trèves R, Bonnabau H, Bertin P. Pain Center and Department of Rheumatology, University Hospital of Limoges; Clinical Research and Biostatistics Unity, Limoges University, Limoges, France. [Email: pascale.vergne-salle@chu-limoges.fr]





Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil FibroSleep™ Optimized Curcumin Longvida®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health

Natural Remedies

Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue
The Brain Boosting and Fatigue Fighting B-12 The Brain Boosting and Fatigue Fighting B-12
Are You Obtaining the Proper Enzymes? Are You Obtaining the Proper Enzymes?
Breaking Through the Mental Fog Breaking Through the Mental Fog
Herbal Rescue for High Blood Sugar Herbal Rescue for High Blood Sugar

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map